Navigation Links
Intrinsic Therapeutics' Barricaid and Magellan Spine Technologies' DART to Drive European Annulus Repair Market
Date:6/29/2009

Two new products to allow for additional spine treatments performed during discectomy procedures, according to Millennium Research Group

WALTHAM, Mass., June 29 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, new annulus repair devices that have entered the European spinal implant market will be key factors contributing to market growth through 2013. MRG's European Markets for Spinal Implants 2009 report finds that the annulus repair segment will form a niche market within the European spinal implant market that will exceed $670 million by 2013.

In April 2009, the first annulus repair device became available in Europe when Intrinsic Therapeutics' Barricaid device received CE marking. Later that month, Magellan Spine Technologies' Disc Annular Repair Technology (DART) System was also granted approval. As these and other companies increasingly promote their products and train surgeons to use them, adoption of annulus repair devices will grow rapidly through 2013.

"Through 2013 and beyond, companies will continue their efforts to demonstrate the benefits of combining annulus repair devices with discectomies, namely fewer costly revisions," says Kevin Flewwelling, Manager of MRG's Orthopedics division. "This will not only boost surgeon confidence in the procedures, which at the moment is low because the devices are so new, but it will also encourage governments and regulatory bodies across Europe to grant reimbursement for annulus repair devices because it will reduce the number of expensive discectomy revisions."

The accumulation of clinical evidence and socioeconomic data that displays how governments can save money by reducing discectomy revisions will be supported by the entrance of new competitors, such as Anulex Technologies, the 2008 leader of the US annulus repair market. The growth of leading competitors, such as Intrinsic Therapeutics and Anulex Technologies, will result in additional resources available to promote annulus repair technology to European surgeons and governments. This will drive uptake of annulus repair devices and expand procedure volumes.

MRG's European Markets for Spinal Implants 2009 report provides various segments of the spinal fusion implant market as well as the market for spinal nonfusion treatments, such as interspinous process decompression devices, pedicle screw-based dynamic stabilization systems, artificial discs, nuclear disc prostheses, annulus repair devices, and facet arthroplasty devices. This report allows clients to assess the effects of the economic downturn, plan for the future, tap into deep segmentation, and leverage up-to-date market shares and in-depth qualitative insights for France, Germany, Italy, Spain and the UK.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis
2. Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review
3. Prospect Therapeutics Inc.s GCS-100 Has Focused on Developing Treatment for Three Blood-Borne Cancers
4. Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
5. Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations
6. Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit
7. Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System
8. Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
9. Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement
10. Prospect Therapeutics In Vitro Studies Demonstrate that GCS-100 Drug Binds to and Blocks the Effects of Galectin-3
11. Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Issuance and Sale of Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced ... test throughout the Northeast U.S. , GlycoMark is the only clinically available ... test provides a clinically proven one- to two-week measure of hyperglycemic excursions, often ...
(Date:4/28/2017)... ... 28, 2017 , ... Children and adolescents who enter the ... children in the general population. That’s because foster care is designed to protect ... While no fault of their own, youth who have experienced trauma often have ...
(Date:4/28/2017)... ... April 28, 2017 , ... Bill Howe started his sewer and drain ... After Tina Howe joined the team, the Bill Howe brand was born and they ... rates, and giving back to the San Diego community in which they worked, lived ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/27/2017)... ... 27, 2017 , ... Today, Jefferson Health in Philadelphia and ... an agreement to create the Jane and Leonard Korman Respiratory Institute in Philadelphia. ... Korman Family Foundation. The collaboration leverages the strengths of each organization and will ...
Breaking Medicine News(10 mins):
(Date:4/26/2017)... PROVIDENCE, N.J. , April 26, 2017 Phoenix ... announce its fifteenth year of fulfilling its mission of transforming ... industry is highly scrutinized, Phoenix,s innovative ... the healthcare community about the latest advances in science and ... Phoenix was founded in 2002 by ...
(Date:4/21/2017)... 21, 2017 Halo Labs announces the launch ... analysis system called the Horizon at PEGS 2017 in ... new system analyzes sub visible particulate matter in biopharmaceutical ... screening as early as candidate selection and pre-formulation. ... contract research organization Elion Labs for system ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
Breaking Medicine Technology: